Futura Medical Share Discussion Threads

[lbo] 22/4/2023 17:00

Liberum says ‘other potential sources of income’

Like a convertible loan! Like Flexiseq did! LOL




The secured loan of US$15 million, which matures on June 25, 2018, will bear interest at 12% per annum plus other additional consideration. The interest rate will decrease to 10% if Pro Bono Bio meets certain equity-fundraising targets. The loan is secured by a charge over the assets of Pro Bono Bio and its affiliates which includes but is not limited to Flexiseq™, an innovative topical pain product that has sales of more than 3 million units since its U.K. launch last year.

[lbo] 22/4/2023 16:52

‘ how successful’ indeed! LOL





2013

Chemist shops sold out of new treatment three times since product came out in June

flying off pharmacy shelves at the rate of 15,000 tubes a week



In 2017, PBB was on the verge of bankruptcy, because it could not pay interest on the loan of 15 million pounds, taken in 2015 by the Canadian Knight Therapeutics.

[j777j] 22/4/2023 16:17

Now main page of Boots.com

[broomrigg] 22/4/2023 16:04

Most of us have the broke nutjob filtered.

[dozey3] 22/4/2023 15:45

I find the filter very useful on this board in order to cut out repetition and deviation by you-know-who.
Onwards and upwards.

[lbo] 22/4/2023 15:21

LOL

Strangely the multi-ID ramper also doesn’t mention how brokers price targets can be very wrong! Which is why they always give all the necessary disclaimers and assumptions they are relying on to get to those targets! The shares collapsed to below 10p soon after these research notes! LOL

[lbo] 22/4/2023 15:03

Strangely the multi-ID ramper copy all the Liberum disclaimers, the disclosures and the assumptions that the research and price target is based upon! LOL





Like the brokers admitting in their previous research they are assuming the original Med2002/2005 patents which expire in 2025 in EU and USA in 2028 will provide some protection to Med3000 until then. Thats a big assumption as the original patent was an umbrella patent covering Dermasys with GTN. Med3000 is just Dermasys on its own which dates back to 2002 and is now just a medical device delivering only a cooling sensation via ˜evaporative cooling’

Also just like it was also believed by brokers at one time that PET500 and CSD500 would generate millions of pounds of revenues for shareholders. Yet they didn’t and both failed to meet previously believed expectations! ROFLMAO




‘These forward-looking statements may use words such as "aim", "anticipate", "believe", "could", "may", "intend", "estimate", "expect" and words of similar meaning. By their nature, all forward-looking statements involve risk and uncertainty because they relate to future events and circumstances which are beyond the control of the Company’



It was estimated that CSD500 could capture about 6 per cent of the condom branded market, which would mean roughly £35m a year in sales for SSL. Assuming a percentage royalty take for Futura in the late teens, CSD500 could be generating over £6m a year in sales for the group

And ‘Futura estimated it would receive royalties of £1.7-2.5m per annum per 1% of global market share

[lbo] 22/4/2023 15:00

‘other potential sources of income’

Like a convertible loan! LOL



In 2017, PBB was on the verge of bankruptcy, because it could not pay interest on the loan of 15 million pounds, taken in 2015 by the Canadian Knight Therapeutics.



LBO - 13 Mar 2023 - 12:50:45 - 17147 of 18236
How long before another ˜innovative deal’ for funding via a convertible loan which converts at a hefty discount is on the way for the USA like was done with China.? Hedge their bets in terms of being able to continue paying all the salaries, bonuses and options even if a possible issue/delay with the De Novo medical device registration arises and the current cash runway runs out!

Market Cap is now over £140m for a company with Zero revenues and no real enforceable patent on a placebo gel that is just made of alcohol, water, glycol and Carbopol!






Death-Spiral Convertible Financier Has a Lot of Fun

[lbo] 22/4/2023 11:52

‘ great to have cash coming in now’ LOL

From Trinity:

˜visibility is currently limited on the magnitude of potential revenues’

From Liberum

˜ Futura expects to generate maiden commercial revenues’

MAIDEN!? LOL

Will it even be enough to cover the annual salaries and bonuses!?

˜Given the lack of visibility with regards to either timing or quantum of these revenues’

˜ We leave our forecasts largely unchanged’



a agreed percentage of the net sales value (after transport costs, sales tax, credit notes for returns and defective products and any settlement, retrospective, volume and promotional discounts) charged by LRC or any sub-licensee in relation to the Product.

The royalty and the royalty advance may be reduced by such amount (if any) as is agreed or determined by an expert to be fair and reasonable if: (i) any patent application does not proceed to grant or any patent rights are determined to be unenforceable or are revoked or lapse; or (ii) an event occurs which in LRC reasonable opinion adversely affects the commercial viability of the licence agreement or the margins on sales of the Product; or (iii) a competing product is offere

[broomrigg] 22/4/2023 11:49

Yes oxford, great to have cash coming in now and looking forward to seeing an RNS relating to that. Other RNSs confirming commencement of sales in other countries surely on their way too. FDA approval this quarter will be the icing on top but even without that the worldwide market is huge. Happy days :-)Sales check on the boots.com website at 11.46......last sale of Eroxon 32 seconds ago.

[lbo] 22/4/2023 11:17

LOL



2013

Chemist shops sold out of new treatment three since times since product came out in June

flying off pharmacy shelves at the rate of 15,000 tubes a week’




In 2017, PBB was on the verge of bankruptcy, because it could not pay interest on the loan of 15 million pounds, taken in 2015 by the Canadian Knight Therapeutics.

[oxford43] 22/4/2023 10:54

It is now the first product on the Boots home page. Must be their best selling product currently.

[broomrigg] 22/4/2023 10:23

LollllSales check 1021 hrs ......Last Eroxon sale via boots.com..... 2 seconds ago.You gotta love it

[petroc] 22/4/2023 09:30

LiarBO, fingers in ears, 'Nanananana nanana Pumpty Dumpty sat on a wall nanananana!'

[broomrigg] 22/4/2023 07:54

Quick check on the boots.com website at 0752 hrs....Last purchase of Eroxon 9 seconds ago.Say no more Rodders :-)

[petroc] 21/4/2023 19:49

It seems to me that the main Promescent product, who LiarBO seems to be promoting now, is a delay spray. He's gonna need a hell of a lot of it to stop the rise of Eroxon!

[broomrigg] 21/4/2023 19:48

Eroxon now on the boots.com home page under "top health picks"

PS Last sale of Eroxon 9 seconds ago